Repository logo

Discovery of sulfonamide-tethered isatin derivatives as novel anticancer agents and VEGFR-2 inhibitors.

Published version

Repository DOI



Change log


Almahli, Hadia 
Badi, Rehab Mustafa 
Khaleel, Eman F 


In this work, new isatin-based sulphonamides (6a-i, 11a-c, 12a-c) were designed and synthesised as potential dual VEGFR-2 and carbonic anhydrase inhibitors with anticancer activities. Firstly, all target isatins were examined for in vitro antitumor action on NCI-USA panel (58 tumour cell lines). Then, the most potent derivatives were examined for the potential CA inhibitory action towards the physiologically relevant hCA isoforms I, II, and tumour-linked hCA IX isoform, in addition, the VEGFR-2 inhibitory activity was evaluated. The target sulphonamides failed to inhibit the CA isoforms that could be attributable to the steric effect of the neighbouring methoxy group, whereas they displayed potent VEGFR-2 inhibitory effect. Following that, isatins 11b and 12b were tested for their influence on the cell cycle disturbance, and towards the apoptotic potential. Finally, detailed molecular modelling analyses, including docking and molecular dynamics, were carried out to assess the binding mode and stability of target isatins.



Synthesis, VEGFR-2 inhibitors, antitumor agents, biological activities, molecular dynamics, Molecular Structure, Structure-Activity Relationship, Carbonic Anhydrases, Isatin, Vascular Endothelial Growth Factor Receptor-2, Antineoplastic Agents, Sulfonamides, Carbonic Anhydrase Inhibitors, Carbonic Anhydrase IX, Antigens, Neoplasm

Journal Title

J Enzyme Inhib Med Chem

Conference Name

Journal ISSN


Volume Title



Informa UK Limited